Open menu
View all staff
Doctor Chris Hanley

Doctor Chris Hanley

 BSc, MRes, PhD
Lecturer in Quantitative Cell Biology

Research interests

  • Tumour microenvironment
  • Fibroblasts and the Extracellular Matrix
  • Quantitative Cell Biology

More research

Accepting applications from PhD students.

Connect with Chris

Email: c.j.hanley@soton.ac.uk

Address: Southampton General Hospital, Tremona Road Shirley, SO16 6YD (View in Google Maps)

ORCID
Research Publications Supervision

Research

Research groups

Research interests

  • Tumour microenvironment
  • Fibroblasts and the Extracellular Matrix
  • Quantitative Cell Biology
  • 3D Model systems
  • Digital Pathology

Research projects

Active projects

Investigating the role of fibroblast subpopulations in lung adenocarcinoma disease progression and response to treatment
Sponsor: Rosetrees Trust
Cancer-associated fibroblast macrophage crosstalk in tumours: characterising phenotypes and functions
Sponsor: Gilead Sciences Inc
Characterising the HNSCC multicellular ecosystem using scRNA-seq
Sponsor: Gilead Sciences Inc
Illuminating the complex rearrangement landscape of sarcoma
Sponsor: The Pathological Society of Great Britain & Ireland
Understanding Cancer-associated Fibroblast Phenotype And Function In Head & Neck Cancer: Targeting Strategies To Overcome Immunotherapy Resistance
Sponsor: Cancer Research UK

Completed projects

Reconstructing the lung cancer microenvironment in vitro: investigating the interplay between cancer-associated fibroblasts and T-lymphocytes
Sponsor: British Lung Foundation
Hanley, CRUK, Developing a 3D model to study tumour-stroma/immune interactions in lung cancer in real time
Researchers:
Doctor Chris Hanley
Sponsor: Cancer Research UK
Characterising cancer-associated fibroblast heterogeneity in lung cancer: relating molecular phenotype to function
Sponsor: Medical Research Council
Combination immunotherapy for breast cancer: targeting cancer-associated fibroblasts to improving therapeutic vaccination
Sponsor: Cancer Research UK
Targeting cancer-associated fibroblasts via NOX1/4 inhibition: adjunctive therapy for oral cancer treatment
Sponsor: Cancer Research UK
How to edit profile
Back to top